Form 4: MicroStrategy Executive Exercises Options and Sells Shares Under Pre-Arranged Plan

Sentiment:

Insider Transaction Report


MicroStrategy's EVP & General Counsel, Shao Wei-Ming, exercised 10,000 stock options and subsequently sold 9,900 Class A Common Stock shares on July 11, 2025, pursuant to a Rule 10b5-1 trading plan.

Summary

  • Shao Wei-Ming, EVP & General Counsel of MicroStrategy Inc., engaged in transactions involving the company's Class A Common Stock on July 11, 2025.
  • Exercised 10,000 employee stock options at an exercise price of $40.46 per share.
  • Sold a total of 9,900 Class A Common Stock shares in multiple transactions at weighted average prices ranging from $425.08 to $437.825.
  • The transactions were conducted under a Rule 10b5-1(c) trading plan, indicating they were pre-scheduled.
  • Following these transactions, Shao Wei-Ming directly holds 12,726 Class A Common Stock shares, 3,527 Series A Perpetual Stride Preferred Stock shares, and 500 Series A Perpetual Strife Preferred Stock shares.
  • Remaining employee stock options total 150,000 shares, with scheduled vesting dates on February 17, 2024 (50,000 shares), February 17, 2025 (50,000 shares), and February 17, 2026 (50,000 shares).

Sentiment

Score: 5

Explanation: Neutral. While there is a sale of shares, it is offset by the exercise of options and the fact that the transaction was pre-planned under a Rule 10b5-1 plan, which mitigates negative sentiment often associated with insider sales.

Positives

  • The exercise of 10,000 employee stock options indicates the executive is realizing value from their compensation, which can be seen as a positive for the executive.
  • The transactions were conducted under a Rule 10b5-1(c) plan, indicating they were pre-scheduled and not based on immediate, non-public information.

Negatives

  • The sale of 9,900 Class A Common Stock shares by a key executive reduces insider ownership, which can sometimes be interpreted negatively by investors, although mitigated by the 10b5-1 plan.

Future Outlook

NA

Industry Context

This document details specific insider transactions for MicroStrategy Inc. and does not provide information directly related to broader industry trends or competitive landscape beyond the company's stock performance at the time of the transactions.

Related Party Transactions

  • Shao Wei-Ming, an executive of MicroStrategy Inc., engaged in transactions involving the company's Class A Common Stock, which are considered related party transactions due to his insider status.

Stakeholder Impact

  • Shareholders: The sale of shares by an executive could be perceived as a slight negative signal, but the pre-arranged nature (10b5-1 plan) mitigates concerns about opportunistic selling. The exercise of options indicates the executive is realizing value from their compensation.

Next Steps

  • MicroStrategy Incorporated (d/b/a Strategy), any security holder of Strategy, or the staff of the Securities and Exchange Commission can request full information regarding the number of shares sold at each price within the reported ranges.
  • Future vesting of 150,000 employee stock options is scheduled for February 17, 2024, February 17, 2025, and February 17, 2026.

Key Dates

DateDescription
02/17/2023Vesting date for 10,000 shares of employee stock options that were exercised.
02/17/2024Vesting date for 50,000 shares of employee stock options.
02/17/2025Vesting date for 50,000 shares of employee stock options.
07/11/2025Date of stock option exercise and subsequent sale of Class A Common Stock by Shao Wei-Ming.
07/15/2025Filing date of the SEC Form 4.
02/17/2026Scheduled vesting date for 50,000 shares of employee stock options.
02/17/2032Expiration date of the employee stock option.

Recommendation

hold

Keywords

MicroStrategy, MSTR, SEC Form 4, Insider Trading, Stock Options, Share Sale, Executive Compensation, Rule 10b5-1, Shao Wei-Ming, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.